Current concepts: Thrombosis of the cerebral veins and sinuses

New England Journal of Medicine

Volumn 352, Issue 17, 2005, Pages 1791-1798

  Stam, Jan ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ASPARAGINASE; HEPARIN; ORAL CONTRACEPTIVE AGENT; ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT;

ANTICOAGULANT THERAPY; BLOOD BRAIN BARRIER; BLOOD CLOT LYSIS; BRAIN EDEMA; BRAIN VEIN; CEREBRAL SINUS THROMBOSIS; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DRUG INDUCED DISEASE; EDEMA; GENETIC DISORDER; HEMATOLOGIC DISEASE; HUMAN; INFECTION; INFLAMMATORY DISEASE; INJURY; INTRACRANIAL HYPERTENSION; LUMBAR PUNCTURE; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYMPTOMATOLOGY; VEIN OCCLUSION; VEIN THROMBOSIS; CRANIAL SINUS; PATHOLOGY; RADIOGRAPHY;

ANTICOAGULANTS; CEREBRAL VEINS; CRANIAL SINUSES; FIBRINOLYTIC AGENTS; HUMANS; INTRACRANIAL HYPERTENSION; RISK FACTORS; SINUS THROMBOSIS, INTRACRANIAL; VENOUS THROMBOSIS;

EID: 17844369421     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMra042354     Document Type: Review

References (48)

1. Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004;35:664-70.
2. Majoie CB, van Straten M, Venema HW, den Heeten GJ. Multisection CT venography of the dural sinuses and cerebral veins by using matched mask bone elimination. AJNR Am J Neuroradiol 2004;25:787-91.
3. Corvol JC, Oppenheim C, Manai R, et al. Diffusion-weighted magnetic resonance imaging in a case of cerebral venous thrombosis. Stroke 1998;29:2649-52.
4. Yoshikawa T, Abe O, Tsuchiya K, et al. Diffusion-weighted magnetic resonance imaging of dural sinus thrombosis. Neuroradiology 2002;44:481-8.
5. Bousser M-G, Ross Russell RW. Cerebral venous thrombosis. London: W.B. Saunders, 1997.
6. deVeber G, Andrew M. Cerebral sinovenous thrombosis in children. N Engl J Med 2001;345:417-23.
7. Deschiens MA, Conard J, Horellou MH, et al. Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis. Stroke 1996;27:1724-30.
8. Enevoldson TP, Russell RW. Cerebral venous thrombosis: new causes for an old syndrome? QJ Med 1990;77:1255-75.
9. Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci PM. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med 1998;338:1793-7.
10. Ludemann P, Nabavi DG, Junker R, et al. Factor V Leiden mutation is a risk factor for cerebral venous thrombosis: a case-control study of 55 patients. Stroke 1998;29:2507-10.
11. Weih M, Junge-Hulsing J, Mehraein S, Ziemer S, Einhaupl KM. Hereditare Thrombophilien bei ischamischem Schlaganfall und Sinusvenenthrombosen: Diagnostik, Therapie und Meta-Analyse. Nervenarzt 2000;71:936-45.
12. Reuner KH, Ruf A, Grau A, et al. Prothrombin gene G20210→A transition is a risk factor for cerebral venous thrombosis. Stroke 1998;29:1765-9.
13. Hillier CE, Collins PW, Bowen DJ, Bowley S, Wiles CM. Inherited prothrombotic risk factors and cerebral venous thrombosis. QJM 1998;91:677-80.
14. Cantu C, Alonso E, Jara A, et al. Hyperhomocysteinemia, low folate and vitamin B12 concentrations, and methylene tetrahydrofolate reductase mutation in cerebral venous thrombosis. Stroke 2004;35:1790-4.
15. Carhuapoma JR, Mitsias P, Levine SR. Cerebral venous thrombosis and anticardiolipin antibodies. Stroke 1997;28:2363-9.
16. Cantu C, Barinagarrementeria F. Cerebral venous thrombosis associated with pregnancy and puerperium: review of 67 cases. Stroke 1993;24:1880-4.
17. Lanska DJ, Kryscio RJ. Risk factors for peripartum and postpartum stroke and intracranial venous thrombosis. Stroke 2000;31:1274-82.
18. Vidailhet M, Piette JC, Wechsler B, Bousser MG, Brunet P. Cerebral venous thrombosis in systemic lupus erythematosus. Stroke 1990;21:1226-31.
19. Daif A, Awada A, al-Rajeh S, et al. Cerebral venous thrombosis in adults: a study of 40 cases from Saudi Arabia. Stroke 1995;26:1193-5.
20. Farah S, Al-Shubaili A, Montaser A, et al. Behcet's syndrome: a report of 41 patients with emphasis on neurological manifestations. J Neurol Neurosurg Psychiatry 1998;64:382-4.
21. Wermes C, Fleischhack G, Junker R, et al. Cerebral venous sinus thrombosis in children with acute lymphoblastic leukemia carrying the MTHFR TT677 genotype and further prothrombotic risk factors. Klin Padiatr 1999;211:211-4.
22. Hillmen P, Lewis SM, Bessler M, Luzzatto L, Dacie JV. Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med 1995;333:1253-8.
23. de Bruijn SF, Stam J, Koopman MM, Vandenbroucke JP. Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users and in [correction of who are] carriers of hereditary prothrombotic conditions. BMJ 1998;316:589-92. [Erratum, BMJ 1998;316:822.]
24. Stiefel D, Eich G, Sacher P. Posttraumatic dural sinus thrombosis in children. Eur J Pediatr Surg 2000;10:41-4.
25. Wilder-Smith E, Kothbauer-Margreiter I, Lammle B, Sturzenegger M, Ozdoba C, Hauser SP. Dural puncture and activated protein C resistance: risk factors for cerebral venous sinus thrombosis. J Neurol Neurosurg Psychiatry 1997;63:351-6.
26. de Bruijn SF, Stam J, Vandenbroucke JP. Increased risk of cerebral venous sinus thrombosis with third-generation oral contraceptives. Lancet 1998;351:1404.
27. Krayenbühl HA. Cerebral venous and sinus thrombosis. Clin Neurosurg 1966;14:1-24.
28. de Bruijn SFTM, ed. Cerebral venous sinus thrombosis: clinical and epidemiological studies. Amsterdam: Thesis, 1998.
29. Vandenbroucke JP, Rosing J, Bloemenkamp KW, et al. Oral contraceptives and the risk of venous thrombosis. N Engl J Med 2001;344:1527-35.
30. Aidi S, Chaunu MP, Biousse V, Bousser MG. Changing pattern of headache pointing to cerebral venous thrombosis after lumbar puncture and intravenous high-dose corticosteroids. Headache 1999;39:559-64.
31. de Bruijn SF, Stam J, Rappelle LJ. Thunderclap headache as first symptom of cerebral venous sinus thrombosis. Lancet 1996;348:1623-5.
32. Kothare SV, Ebb DH, Rosenberger PB, Buonanno F, Schaefer PW, Krishnamoorthy KS. Acute confusion and mutism as a presentation of thalamic strokes secondary to deep cerebral venous thrombosis. J Child Neurol 1998;13:300-3.
33. Lafitte F, Boukobza M, Guichard JP, et al. MRI and MRA for diagnosis and follow-up of cerebral venous thrombosis (CVT). Clin Radiol 1997;52:672-9.
34. Dormont D, Anxionnat R, Evrard S, Louaille C, Chiras J, Marsault C. MRI in cerebral venous thrombosis. J Neuroradiol 1994;21:81-99.
35. Isensee C, Reul J, Thron A. Magnetic resonance imaging of thrombosed dural sinuses. Stroke 1994;25:29-34.
36. Ayanzen RH, Bird CR, Keller PJ, McCully FJ, Theobald MR, Heiserman JE. Cerebral MR venography: normal anatomy and potential diagnostic pitfalls. AJNR Am J Neuroradiol 2000;21:74-8.
37. de Bruijn SF, de Haan RJ, Stam J. Clinical features and prognostic factors of cerebral venous sinus thrombosis in a prospective series of 59 patients. J Neurol Neurosurg Psychiatry 2001;70:105-8.
38. Stefini R, Latronico N, Cornali C, Rasulo F, Bollati A. Emergent decompressive craniectomy in patients with fixed dilated pupils due to cerebral venous and dural sinus thrombosis: report of three cases. Neurosurgery 1999;45:626-9.
39. Diaz JM, Schiffman JS, Urban ES, Maccario M. Superior sagittal sinus thrombosis and pulmonary embolism: a syndrome rediscovered. Acta Neurol Scand 1992;86:390-6.
40. Einhaupl KM, Villringer A, Meister W, et al. Heparin treatment in sinus venous thrombosis. Lancet 1991;338:597-600. [Erratum, Lancet 1991;338:958.]
41. de Bruijn SF, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 1999;30:484-8.
42. Nagaraja D, Rao BSS, Taly AB, Subhash MN. Randomized controlled trial of heparin in puerperal cerebral venous/sinus thrombosis. Nimhans J 1995;13:111-5.
43. Stam J, De Bruijn SF, DeVeber G. Anticoagulation for cerebral sinus thrombosis. Cochrane Database Syst Rev 2002;4:CD002005.
44. Bousser MG. Cerebral venous thrombosis: nothing, heparin, or local thrombolysis? Stroke 1999;30:481-3.
45. van den Belt A, Prins MH, Lensing AW, et al. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. Cochrane Database Syst Rev 2002;2:CD001100.
46. Canhão P, Falcao F, Ferro JM. Thrombolytics for cerebral sinus thrombosis: a systematic review. Cerebrovasc Dis 2003;15:159-66.
47. Kesler A, Hadayer A, Goldhammer Y, Almog Y, Korczyn AD. Idiopathic intracranial hypertension: risk of recurrences. Neurology 2004;63:1737-9.
48. Tse DT, Chang WJ. Surgery of the orbit and optic nerve. In: Glaser JS, ed. Neuroophthalmology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 1999:520-3.